Literature DB >> 29280865

Development and Internal Validation of the Abdominoplasty Risk Calculator.

Michael M Vu1, Marco F Ellis, Jordan T Blough, Karol A Gutowski, John Y S Kim.   

Abstract

BACKGROUND: Risk calculators are an emerging tool that provide granular, individualized risk estimation. Presently, there is a paucity of risk calculators specific to plastic surgery. Abdominoplasty is a popular plastic surgery procedure associated with moderate risks of complications, such as surgical-site infection and dehiscence, and would benefit from the ability to provide patients with accurate, personalized risk assessment.
METHODS: Abdominoplasties from the National Surgical Quality Improvement Program 2005 to 2014 database were identified by Current Procedural Terminology code. Relevant perioperative variables included age, body mass index, sex, smoking history, diabetes, American Society of Anesthesiologists class, pulmonary comorbidities, hypertension, bleeding disorders, and operative duration. Multiple logistic regressions were used to generate 30-day risk models for medical complications, surgical-site infection, wound dehiscence, and reoperation. Internal validation of model performance was conducted using C-statistics, Hosmer-Lemeshow tests, and Brier scores.
RESULTS: Among the 2499 cases identified, complication rates were as follows: medical complications, 3.8 percent; superficial surgical-site infection, 2.4 percent; deep or organ-space surgical-site infection, 1.6 percent; wound dehiscence, 1.0 percent; and reoperation, 2.0 percent. Risk prediction models were constructed and all demonstrated good predictive performance, with mean predicted risks closely matching observed complication rates. The distributions of predicted risk were wide and contained outliers with very high risk. A user-friendly, open-access online interface for these models is published at AbdominoplastyRisk.org.
CONCLUSIONS: The authors developed an internally valid risk calculator for which individual patient characteristics can be input to predict 30-day complications after abdominoplasty. Given that estimated risk can vary widely, individualized risk assessment is a way to enhance shared decision-making between surgeon and patient.

Entities:  

Mesh:

Year:  2018        PMID: 29280865     DOI: 10.1097/PRS.0000000000003922

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  6 in total

1.  Accurate risk stratification for development of organ/space surgical site infections after emergent trauma laparotomy.

Authors:  Shuyan Wei; Charles Green; Lillian S Kao; Brandy B Padilla-Jones; Van Thi Thanh Truong; Charles E Wade; John A Harvin
Journal:  J Trauma Acute Care Surg       Date:  2019-02       Impact factor: 3.313

2.  Modified Frailty Index Predicts Postoperative Complications following Panniculectomy in the Elderly.

Authors:  Jasmine Lee; Allyson R Alfonso; Rami S Kantar; Gustave K Diep; Zoe P Berman; Elie P Ramly; David A Daar; Jamie P Levine; Daniel J Ceradini
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-07-21

3.  An Ounce of Prediction is Worth a Pound of Cure: Risk Calculators in Breast Reconstruction.

Authors:  Nicholas C Oleck; Sonali Biswas; Ronnie L Shammas; Hani I Naga; Brett T Phillips
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-05-13

Review 4.  Abdominoplasty: Pitfalls and Prospects.

Authors:  Nayef A Louri; Hamad M Ammar; Fatema Abduljabbar Abdulkariml; Turki Abdulla Sanad Ahmed Eid Alkhaldi; Rashed Noaman AlHasan
Journal:  Obes Surg       Date:  2020-03       Impact factor: 4.129

5.  Standardization and Selection of High-risk Patients for Surgical Wound Infections in Plastic Surgery.

Authors:  Marta Starnoni; Massimo Pinelli; Silvia Porzani; Alessio Baccarani; Giorgio De Santis
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-03-23

6.  Abdominoplasty in the Massive Weight Loss Patient: Are Aesthetic Goals and Safety Mutually Exclusive?

Authors:  Richard J Restifo
Journal:  Aesthet Surg J Open Forum       Date:  2021-04-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.